Search

everythinglearnresearchcommunity

for

Search:↓

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Acne is common and can be linked to various systemic health conditions and syndromes.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Androgenetic alopecia is complex and needs more research for better treatments.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Adult female acne is complex and requires a combination of treatments for effective management.

Myo-inositol improves fertility and metabolic health in PCOS with fewer side effects than metformin.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Genetics, hormones, and microbiome changes contribute to hidradenitis suppurativa.

Nutritional supplements can help manage hair loss and promote hair growth by strengthening hair roots and countering harmful effects of pollution, smoking, and deficiencies in vitamins and minerals.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.